QGEN
QIAGEN N.V.
stockNYSE
qiagen is the leading global provider of sample to insight solutions to transform biological materials into valuable molecular insights. qiagen sample technologies isolate and process dna, rna and proteins from blood, tissue and other materials. assay technologies make these biomolecules visible and ready for analysis. bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. automation solutions tie these together in seamless and cost-effective molecular testing workflows. qiagen provides these workflows to more than 500,000 customers around the world in molecular diagnostics (human healthcare), applied testing (forensics, veterinary testing and food safety), pharma (pharmaceutical and biotechnology companies) and academia (life sciences research). as of june 30, 2015, qiagen employed approximately 4,400 people in over 35 locations worldwide. further information can be found at http://www.qiagen.com.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 45.79 | 2026-10-05 | -0.98% | 2.119 |
| 1M | 42.50 | 2026-09-11 | +6.68% | 1.877 |
| 3M | 41.44 | 2026-07-13 | +9.41% | 0.872 |
| 6M | 41.91 | 2026-04-13 | +8.18% | 0.777 |
| 1Y | 47.22 | 2025-10-13 | -3.98% | 0.442 |
| 2Y | 45.17 | 2024-10-11 | +0.36% | — |
| 5Y | 54.20 | 2021-10-12 | -16.34% | 0.626 |
QIAGEN N.V. (NYSE:QGEN) stock price today is $45.34, and today's volume is 991,309. QGEN is down 0.088% today. The 30 day average volume is 2.07M. QGEN market cap is $9.36B with 206.50M shares outstanding.